Editor, Rwanda is making remarkable strides in addressing the burden of cancer. Partnership with pharmaceuticals like Merrickmak adds momentum and seriousness in the fight against the disease. It’s promising to learn that plans for clinical trials are underway. Kudos to all involved! Philippa Kibugu Reaction to the article, “Global pharmaceutical firm joins Rwanda in cancer fight” (The New Times, November 22)
